Diagnostics
Offerings include RNA, MicroRNA and DNA based molecular diagnostic products providing identification of genetic abnormalities associated with oncology and genetic diseases. Multiplex assay oncology tests for leukemia, including abnormalities associated with CML, BCR/ABL ALL, APL, AML, NPM1, KRAS/BRAF (which are oncogenes associated with epidermal growth factor receptor EGFR), RNA stabilization products with its Armored RNA technology and a genetic test for Fragile X Mental Retardation FMR1.
Read more about this topic: Asuragen